Updated Treatment Strategies in the
Management of Obesity

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session at the 2016 Fall Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2017 to December 31, 2017

Instructions for CME/CNE: Listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.  To print or save your certificate, you will need to click on the “download” button and either print or save.

These presentations require Adobe Flash Player.  You can download it here.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant  from Novo Nordisk, Inc.




Obesity has been shown to be a risk factor for a number of conditions, among them: coronary heart disease, type 2 diabetes, hypertension, stroke, and certain types of cancer. Fortunately, new pharmacologic agents have become available, giving physicians more management options, in addition to a reduced-calorie diet and exercise. Lifestyle changes are extremely important to treating obesity and should always be recommended in conjunction with the medication and require a lifetime behavioral modification which may be boosted with education, the use of support groups, counseling, and perhaps meeting with a dietitian. In light of the increasing prevalence of obesity in the United States, and the challenges in identifying treatment strategies for overweight and obese patients that will produce enduring weight loss, there is an urgent need for evidence-based education on these emerging treatments and strategies that physicians can apply to achieve clinically meaningful weight loss in individuals who meet medical criteria for pharmacologic intervention.

Upon Completion of this activity, participants will be able to:

  • Assess novel treatment advances in the understanding and management of obesity

  • Describe individualized treatment strategies using updated clinical data that combine behavioral therapy, lifestyle modifications, and pharmacotherapy

  • Analyze updated recommendations for obesity management, relative to lifestyle modifications and pharmacologic therapy, in appropriate patients

  • Explore best practices surrounding patient management using evidence-based interventions to motivate and drive adherence to recommended obesity treatment

  • Discuss the importance of devices in development and their use for the management of obesity

Faculty: Holly Wyatt, MD
Associate Director
University of Colorado Anschutz Health and Wellness Center
Medical Director
The Wellness Clinic at the University of Colorado Anschutz Health and Wellness Center
Associate Professor, CU School of Medicine
Division of Endocrinology, Metabolism and Diabetes


Dr. Wyatt serves in an advisory capacity for Atkins, Eisai, Retrofit and Vivus; as a consultant to Takeda. She has received research support from American Beverage Association, DuPont, Gelesis, GI Dynamics, National Cattlemen's Association and NIH. She is on speaker's bureau for CME Insite, IMNE, Inc (CME only), Global Directions in Medicine and Vindico (CME only). In addition, she receives honorarium from American Diabetes Association and the Obesity Society for speaking. Dr. Wyatt receives royalties from "Up to Date", has a patent on "Energy Gap", is a book author "State of Slim" and is an equity owner of Active Planet and Shakabuku, LLC. Her presentation has been peer reviewed.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jacquelyn Smith, RN, BSN, MA, CMCN has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
Will Williams has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The National Association of Managed Care Physicians designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity and turn in a validation form will receive up to 1 credit in continuing nursing education.

The American Board of Managed Care Nurses has approved this activity for a maximum of 1 contact hour towards CMCN recertification.

This presentation is supported by an educational grant  from Novo Nordisk, Inc.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.